Evidence map›Paper›PMID 31216460›Full record

ReviewImmunity2019

Caspases in Cell Death, Inflammation, and Disease.

Nina Van Opdenbosch, Mohamed Lamkanfi

Open access · bronzeAbstract readReview
In one paragraph

Review in Immunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 686 papers.

0numbers the graph read from it
0cells of the map it votes in
686citing papers in PubMed
43.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

686 citing papers in PubMed, 1,193 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Dietary taurine supplementation enhances growth performance of Japanese seabass (Animal nutrition (Zhongguo xu mu shou yi xue hui) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. A non-classical necroptosis pathway mediated by caspases.Cell communication and signaling : CCS · 2026
    Article
  14. Two-StepBiology · 2026
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

626 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Nina Van OpdenboschJanssen Immunosciences, World Without Disease Accelerator, Pharmaceutical Companies of Johnson & Johnson, Beerse, 2340, Belgium.
Mohamed LamkanfiJanssen Immunosciences, World Without Disease Accelerator, Pharmaceutical Companies of Johnson & Johnson, Beerse, 2340, Belgium; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, 9000, Belgium. Electronic address: mlamkanf@its.jnj.com.
Janssen (Belgium) · BE

Funding

European Research Council 683144
6 · The paper itself

Abstract

Caspases are an evolutionary conserved family of cysteine proteases that are centrally involved in cell death and inflammation responses. A wealth of foundational insight into the molecular mechanisms that control caspase activation has emerged in recent years. Important advancements include the identification of additional inflammasome platforms and pathways that regulate activation of inflammatory caspases; the discovery of gasdermin D as the effector of pyroptosis and interleukin (IL)-1 and IL-18 secretion; and the existence of substantial crosstalk between inflammatory and apoptotic initiator caspases. A better understanding of the mechanisms regulating caspase activation has supported initial efforts to modulate dysfunctional cell death and inflammation pathways in a suite of communicable, inflammatory, malignant, metabolic, and neurodegenerative diseases. Here, we review current understanding of caspase biology with a prime focus on the inflammatory caspases and outline important topics for future experimentation.

Indexed as

Disease SusceptibilityAnimalsApoptosisBiomarkersCaspasesCell DeathCytokinesHumansInflammasomesInflammationInflammation MediatorsMolecular Targeted TherapyPyroptosisSignal TransductionBiomarkersCaspasesCytokinesInflammasomesInflammation Mediatorsapoptosiscaspasegasdermininflammasomeinterleukinpyroptosis

Identifiers

PMID31216460
PMCPMC6611727
OpenAlexW2951509935

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.